1 – 10 of 25
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2026
-
Mark
Integration of plasma eMTBR-tau243 and p-tau217 in the diagnosis and stratification of Alzheimer's disease : a prospective cohort study
- Contribution to journal › Article
-
Mark
Eligibility for amyloid targeting therapies among primary care patients with cognitive symptoms
- Contribution to journal › Article
-
Mark
The Role of Clinical, Plasma, and Imaging Biomarkers in Assessing Future Dementia Risk in Individuals With Subjective Cognitive Decline
- Contribution to journal › Article
-
Mark
Clinical staging in Swedish primary care using the Amsterdam Instrumental Activities of Daily Living Questionnaire
- Contribution to journal › Article
-
Mark
Speech-based digital cognitive assessment for clinical trials : Detecting cognitive impairment stages and AD biomarker relations across European cohorts
- Contribution to journal › Article
- 2025
-
Mark
Evaluation of the Revised Criteria for Biological and Clinical Staging of Alzheimer Disease
- Contribution to journal › Article
-
Mark
Connectivity as a universal predictor of tau progression in atypical Alzheimer's disease
- Contribution to journal › Article
-
Mark
Assessing Eligibility for Anti‐Amyloid Treatment Among Primary Care Patients with Cognitive Symptoms
(2025) In Alzheimer's & dementia : the journal of the Alzheimer's Association
- Contribution to journal › Published meeting abstract
-
Mark
Primary care detection of Alzheimer's disease using a self-administered digital cognitive test and blood biomarkers
- Contribution to journal › Article
- 2024
-
Mark
Plasma N-terminal containing tau fragments (NTA-tau) : a biomarker of tau deposition in Alzheimer’s Disease
- Contribution to journal › Article
